Below, a list of constituents for BMED (iShares Health Innovation Active ETF) is shown. In total, BMED consists of 120 securities.
Note: The data shown here is as of date Dec 31, 2024 (the latest that can be sourced directly from the fund provider).
Click here to go back to the full list of ETFs.
| Ticker | Name | Sector | Asset Class | Market Value | Weight (%) |
| ISRG | INTUITIVE SURGICAL INC | Health Care | Equity | 167200.95 | 5.26 |
| BSX | BOSTON SCIENTIFIC CORP | Health Care | Equity | 161613.76 | 5.08 |
| ARGX | ARGENX SE ADR | Health Care | Equity | 113100.32 | 3.56 |
| GILD | GILEAD SCIENCES INC | Health Care | Equity | 99757.32 | 3.14 |
| ROG | ROCHE HOLDING PAR AG | Health Care | Equity | 90559.14 | 2.85 |
| LONN | LONZA GROUP AG | Health Care | Equity | 86518.45 | 2.72 |
| XTSLA | BLK CSH FND TREASURY SL AGENCY | Cash and/or Derivatives | Money Market | 80000.0 | 2.51 |
| ABT | ABBOTT LABORATORIES | Health Care | Equity | 76941.55 | 2.42 |
| UCB | UCB SA | Health Care | Equity | 73974.36 | 2.33 |
| MDT | MEDTRONIC PLC | Health Care | Equity | 68983.86 | 2.17 |
| RGEN | REPLIGEN CORP | Health Care | Equity | 66505.92 | 2.09 |
| WAT | WATERS CORP | Health Care | Equity | 65790.4 | 2.07 |
| BMY | BRISTOL MYERS SQUIBB | Health Care | Equity | 65165.65 | 2.05 |
| TECH | BIO TECHNE CORP | Health Care | Equity | 62035.05 | 1.95 |
| NBIX | NEUROCRINE BIOSCIENCES INC | Health Care | Equity | 61240.8 | 1.93 |
| NTRA | NATERA INC | Health Care | Equity | 59324.16 | 1.86 |
| ABBV | ABBVIE INC | Health Care | Equity | 57042.0 | 1.79 |
| PODD | INSULET CORP | Health Care | Equity | 55780.0 | 1.75 |
| EW | EDWARDS LIFESCIENCES CORP | Health Care | Equity | 51464.98 | 1.62 |
| EXAS | EXACT SCIENCES CORP | Health Care | Equity | 50102.68 | 1.57 |
| DHR | DANAHER CORP | Health Care | Equity | 49922.58 | 1.57 |
| TMO | THERMO FISHER SCIENTIFIC INC | Health Care | Equity | 48687.5 | 1.53 |
| ONC | BEIGENE ADS REPRESENTING LTD | Health Care | Equity | 46907.7 | 1.47 |
| SRPT | SAREPTA THERAPEUTICS INC | Health Care | Equity | 46548.29 | 1.46 |
| DXCM | DEXCOM INC | Health Care | Equity | 45875.35 | 1.44 |
| WST | WEST PHARMACEUTICAL SERVICES INC | Health Care | Equity | 45836.08 | 1.44 |
| GH | GUARDANT HEALTH INC | Health Care | Equity | 41956.74 | 1.32 |
| SRT3 | SARTORIUS PREF AG | Health Care | Equity | 41817.97 | 1.31 |
| HOLX | HOLOGIC INC | Health Care | Equity | 39732.88 | 1.25 |
| RYTM | RHYTHM PHARMACEUTICALS INC | Health Care | Equity | 39210.6 | 1.23 |
| AMGN | AMGEN INC | Health Care | Equity | 35531.01 | 1.12 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | Health Care | Equity | 34593.3 | 1.09 |
| A | AGILENT TECHNOLOGIES INC | Health Care | Equity | 32549.97 | 1.02 |
| BPMC | BLUEPRINT MEDICINES CORP | Health Care | Equity | 31554.5 | 0.99 |
| PEN | PENUMBRA INC | Health Care | Equity | 31270.0 | 0.98 |
| XENE | XENON PHARMACEUTICALS INC | Health Care | Equity | 30374.4 | 0.95 |
| QGEN | QIAGEN NV | Health Care | Equity | 29022.08 | 0.91 |
| LH | LABCORP HOLDINGS INC | Health Care | Equity | 28999.62 | 0.91 |
| EXEL | EXELIXIS INC | Health Care | Equity | 26928.72 | 0.85 |
| UTHR | UNITED THERAPEUTICS CORP | Health Care | Equity | 26593.5 | 0.84 |
| BDX | BECTON DICKINSON | Health Care | Equity | 25751.44 | 0.81 |
| SYK | STRYKER CORP | Health Care | Equity | 25424.1 | 0.8 |
| SNY | SANOFI ADR REPRESENTING SA | Health Care | Equity | 25287.9 | 0.79 |
| DNLI | DENALI THERAPEUTICS INC | Health Care | Equity | 24155.04 | 0.76 |
| IQV | IQVIA HOLDINGS INC | Health Care | Equity | 24092.31 | 0.76 |
| MRUS | MERUS NV | Health Care | Equity | 23964.05 | 0.75 |
| BIIB | BIOGEN INC | Health Care | Equity | 23913.12 | 0.75 |
| PFE | PFIZER INC | Health Care | Equity | 23344.2 | 0.73 |
| ZEAL | ZEALAND PHARMA | Health Care | Equity | 23278.01 | 0.73 |
| INSM | INSMED INC | Health Care | Equity | 22040.04 | 0.69 |
| SOON | SONOVA HOLDING AG | Health Care | Equity | 21834.93 | 0.69 |
| PTCT | PTC THERAPEUTICS INC | Health Care | Equity | 21304.26 | 0.67 |
| ILMN | ILLUMINA INC | Health Care | Equity | 20976.0 | 0.66 |
| GKOS | GLAUKOS CORP | Health Care | Equity | 19822.16 | 0.62 |
| NVCR | NOVOCURE LTD | Health Care | Equity | 19095.0 | 0.6 |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | Health Care | Equity | 18727.14 | 0.59 |
| CRL | CHARLES RIVER LABORATORIES INTERNA | Health Care | Equity | 18586.3 | 0.58 |
| NUVL | NUVALENT INC CLASS A | Health Care | Equity | 17903.35 | 0.56 |
| HALO | HALOZYME THERAPEUTICS INC | Health Care | Equity | 17165.4 | 0.54 |
| COO | COOPER INC | Health Care | Equity | 17161.2 | 0.54 |
| BBIO | BRIDGEBIO PHARMA INC | Health Care | Equity | 17128.56 | 0.54 |
| STE | STERIS | Health Care | Equity | 17030.52 | 0.54 |
| ROIV | ROIVANT SCIENCES LTD | Health Care | Equity | 16884.6 | 0.53 |
| ALC | ALCON AG | Health Care | Equity | 16272.0 | 0.51 |
| AZN | ASTRAZENECA PLC | Health Care | Equity | 16093.19 | 0.51 |
| TARS | TARSUS PHARMACEUTICALS INC | Health Care | Equity | 14076.4 | 0.44 |
| IONS | IONIS PHARMACEUTICALS INC | Health Care | Equity | 13494.6 | 0.42 |
| NRIX | NURIX THERAPEUTICS INC | Health Care | Equity | 12734.4 | 0.4 |
| BNTX | BIONTECH SE ADR | Health Care | Equity | 12221.64 | 0.38 |
| BEAM | BEAM THERAPEUTICS INC | Health Care | Equity | 11899.35 | 0.37 |
| TWST | TWIST BIOSCIENCE CORP | Health Care | Equity | 11288.5 | 0.35 |
| 4568 | DAIICHI SANKYO LTD | Health Care | Equity | 10639.27 | 0.33 |
| ASND | ASCENDIS PHARMA ADR REPRESENTING | Health Care | Equity | 10507.56 | 0.33 |
| STOK | STOKE THERAPEUTICS INC | Health Care | Equity | 10126.08 | 0.32 |
| AXSM | AXSOME THERAPEUTICS INC | Health Care | Equity | 10098.42 | 0.32 |
| MTSR | METSERA INC | Health Care | Equity | 8923.8 | 0.28 |
| ALKS | ALKERMES | Health Care | Equity | 8828.12 | 0.28 |
| GMAB | GENMAB | Health Care | Equity | 8668.86 | 0.27 |
| PCVX | VAXCYTE INC | Health Care | Equity | 8565.81 | 0.27 |
| RVMD | REVOLUTION MEDICINES INC | Health Care | Equity | 8048.74 | 0.25 |
| VRTX | VERTEX PHARMACEUTICALS INC | Health Care | Equity | 7996.29 | 0.25 |
| SRRK | SCHOLAR ROCK HOLDING CORP | Health Care | Equity | 7969.95 | 0.25 |
| INSP | INSPIRE MEDICAL SYSTEMS INC | Health Care | Equity | 7677.6 | 0.24 |
| BHVN | BIOHAVEN LTD | Health Care | Equity | 7315.74 | 0.23 |
| EWTX | EDGEWISE THERAPEUTICS INC | Health Care | Equity | 6683.4 | 0.21 |
| ARVN | ARVINAS INC | Health Care | Equity | 6669.0 | 0.21 |
| RNA | AVIDITY BIOSCIENCES INC | Health Care | Equity | 6392.0 | 0.2 |
| RCKT | ROCKET PHARMACEUTICALS INC | Health Care | Equity | 5955.84 | 0.19 |
| ACLX | ARCELLX INC | Health Care | Equity | 5893.16 | 0.19 |
| PTGX | PROTAGONIST THERAPEUTICS INC | Health Care | Equity | 4984.8 | 0.16 |
| NYXH | NYXOAH SA | Health Care | Equity | 4914.0 | 0.15 |
| DYN | DYNE THERAPEUTICS INC | Health Care | Equity | 4577.1 | 0.14 |
| USD | USD CASH | Cash and/or Derivatives | Cash | 4548.32 | 0.14 |
| IRON | DISC MEDICINE INC | Health Care | Equity | 4344.21 | 0.14 |
| TCRX | TSCAN THERAPEUTICS INC | Health Care | Equity | 4072.68 | 0.13 |
| ORIC | ORIC PHARMACEUTICALS INC | Health Care | Equity | 3978.8 | 0.13 |
| RCUS | ARCUS BIOSCIENCES INC | Health Care | Equity | 3590.4 | 0.11 |
| VIR | VIR BIOTECHNOLOGY INC | Health Care | Equity | 3393.2 | 0.11 |
| VYGR | VOYAGER THERAPEUTICS INC | Health Care | Equity | 3118.05 | 0.1 |
| GPCR | STRUCTURE THERAPEUTICS ADR INC | Health Care | Equity | 3033.45 | 0.1 |
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Health Care | Equity | 2686.0 | 0.08 |
| AUTL | AUTOLUS THERAPEUTICS ADR PLC | Health Care | Equity | 2576.31 | 0.08 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS CLASS | Health Care | Equity | 2400.75 | 0.08 |
| RGNX | REGENXBIO INC | Health Care | Equity | 2392.92 | 0.08 |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | Health Care | Equity | 2379.98 | 0.07 |
| IMTX | IMMATICS NV | Health Care | Equity | 2371.5 | 0.07 |
| WVE | WAVE LIFE SCIENCES LTD | Health Care | Equity | 2312.7 | 0.07 |
| VKTX | VIKING THERAPEUTICS INC | Health Care | Equity | 2206.4 | 0.07 |
| ALLO | ALLOGENE THERAPEUTICS INC | Health Care | Equity | 1968.93 | 0.06 |
| ACIU | AC IMMUNE SA | Health Care | Equity | 1892.7 | 0.06 |
| BCYC | BICYCLE THERAPEUTICS ADR PLC | Health Care | Equity | 1861.02 | 0.06 |
| SYRE | SPYRE THERAPEUTICS INC | Health Care | Equity | 1213.7 | 0.04 |
| FDMT | 4D MOLECULAR THERAPEUTICS INC | Health Care | Equity | 1049.61 | 0.03 |
| VIGL | VIGIL NEUROSCIENCE INC | Health Care | Equity | 900.24 | 0.03 |
| nan | ABIOMED CVRS | Health Care | Equity | 528.9 | 0.02 |
| SEPN | SEPTERNA INC | Health Care | Equity | 515.13 | 0.02 |
| LXEO | LEXEO THERAPEUTICS INC | Health Care | Equity | 294.15 | 0.01 |
| MRTX | MIRATI THERAPEUTICS INC | Health Care | Equity | 247.16 | 0.01 |
| KRRBIO | KORRO BIO INC CVR | Health Care | Equity | 0.0 | 0.0 |
| The content contained herein is owned or licensed by BlackRock and/or its third-party information providers and is protected by applicable copyrights, trademarks, service marks, and/or other intellectual property rights. Such content is solely for your personal, non-commercial use. Accordingly, you may not copy, distribute, modify, post, frame or deep link this content. You may download material displayed on this Website for your personal use provided you also retain all copyright and other proprietary notices contained on the materials. Modification or use of the materials for any other purpose violates BlackRock's intellectual property rights. Holdings subject to change. See www.iShares.com for the most recent funds holdings. The values for “price” shown herein generally represent a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The values shown herein for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of the vendor price and may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent practicable date and may not necessarily be as of the date shown above. Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures. CAREFULLY CONSIDER THE FUNDS' INVESTMENT OBJECTIVES, RISK FACTORS, AND CHARGES AND EXPENSES BEFORE INVESTING. THIS AND OTHER INFORMATION CAN BE FOUND IN THE FUNDS' PROSPECTUSES OR, IF AVAILABLE, THE SUMMARY PROSPECTUSES WHICH MAY BE OBTAINED BY VISITING WWW.ISHARES.COM OR WWW.BLACKROCK.COM. READ THE PROSPECTUS CAREFULLY BEFORE INVESTING. INVESTING INVOLVES RISK, INCLUDING POSSIBLE LOSS OF PRINCIPAL. This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. The Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). The iShares Funds are not sponsored, endorsed, issued, sold or promoted by Bloomberg, BlackRock Index Services, LLC, Cboe Global Indices, LLC, Cohen & Steers, European Public Real Estate Association (“EPRA® ”), FTSE International Limited (“FTSE”), ICE Data Indices, LLC, NSE Indices Ltd, JPMorgan, JPX Group, London Stock Exchange Group (“LSEG”), MSCI Inc., Markit Indices Limited, Morningstar, Inc., Nasdaq, Inc., National Association of Real Estate Investment Trusts (“NAREIT”), Nikkei, Inc., Russell, S&P Dow Jones Indices LLC or STOXX Ltd. None of these companies make any representation regarding the advisability of investing in the Funds. With the exception of BlackRock Index Services, LLC, who is an affiliate, BlackRock Investments, LLC is not affiliated with the companies listed above. Neither FTSE, LSEG, nor NAREIT makes any warranty regarding the FTSE Nareit Equity REITS Index, FTSE Nareit All Residential Capped Index or FTSE Nareit All Mortgage Capped Index. Neither FTSE, EPRA, LSEG, nor NAREIT makes any warranty regarding the FTSE EPRA Nareit Developed ex-U.S. Index, FTSE EPRA Nareit Developed Green Target Index or FTSE EPRA Nareit Global REITs Index. “FTSE®” is a trademark of London Stock Exchange Group companies and is used by FTSE under license. ©2023 BlackRock, Inc or its affiliates. All rights reserved. iSHARES, iBONDS and BLACKROCK are trademarks of BlackRock, Inc. or its affiliates. All other trademarks are those of their respective owners. | nan | nan | nan | nan | nan |
Alphalerts is a Chapati Systems GmbH Service.
Made with Chai in Germany.
